New class of spatial technology validated in cancer benchmark study

Benchmark results demonstrate high-resolution performance from FFPE lung squamous cell carcinoma samples.

Date

April 22, 2026

Location

San Jose, California

Read time

4 min read

A broader path to discovery

A benchmark study evaluated spatial single-cell mapping across matched fresh-frozen and FFPE tumour samples, reporting concordant cell-type resolution and preserved molecular sensitivity.

The expanded portfolio supports deeper biological insight from multiomics experiments while remaining designed for seamless integration. Researchers can add a new dimension to existing studies without purchasing a separate specialized instrument or abandoning the platforms already used in their laboratories.

“

Validation on archival tumour tissue is what makes spatial biology usable in translational research.

Technology unlocks new possibilities

Single-cell spatial omics is redefining how scientists study tissue biology by enabling high-resolution maps of gene and protein expression. A straightforward workflow transforms standard single-cell data into spatial insight, and expanded bioinformatics software with dedicated field-application support helps researchers optimize downstream analysis with open-source tools.

Investing in what comes next

Takara Bio USA continues to expand its R&D teams and consolidate manufacturing at its facilities. The investment increases capacity to scale production, respond to global demand, and accelerate development of complementary platforms.